EP 0843671 A1 19980527 - HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
Title (en)
HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
Title (de)
HETEROCYCLISCH VERBINDUNGEN UND DIESE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSTELLUNGEN
Title (fr)
COMPOSES HETEROCYCLIQUES ET COMPOSITIONS PHARMACEUTIQUES A BASE DESDITS COMPOSES
Publication
Application
Priority
- EP 9603026 W 19960711
- GB 9514265 A 19950713
Abstract (en)
[origin: WO9703069A1] The invention is directed toward substituted heteroaromatic compounds which are protein tyrosine kinase inhibitors, in particular to substituted quinolines and quinazolines. Methods for their preparation, pharmaceutical compositions including such compounds and their use in medicine, for example in the treatment of psoriasis, fibrosis, atherosclerosis, restenosis, auto-immune disease, allergy, asthma, transplantation rejection, inflammation, thrombosis, nervous system diseases, and cancer.
IPC 1-7
IPC 8 full level
A61K 31/505 (2006.01); A61P 7/02 (2006.01); A61P 9/10 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07D 401/14 (2006.01); C07D 403/12 (2006.01); C07D 405/14 (2006.01); C07D 491/04 (2006.01)
CPC (source: EP)
A61P 7/02 (2017.12); A61P 9/10 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 405/14 (2013.01); C07D 491/04 (2013.01)
Citation (search report)
See references of WO 9703069A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9703069 A1 19970130; AU 6613996 A 19970210; EP 0843671 A1 19980527; GB 9514265 D0 19950913; HR P960316 A2 19980228; JP H11508906 A 19990803; ZA 965935 B 19980212
DOCDB simple family (application)
EP 9603026 W 19960711; AU 6613996 A 19960711; EP 96925710 A 19960711; GB 9514265 A 19950713; HR P960316 A 19960704; JP 50550397 A 19960711; ZA 965935 A 19960712